Welcome to our dedicated page for Walgreen Boots SEC filings (Ticker: WBA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page aggregates U.S. Securities and Exchange Commission filings for Walgreens Boots Alliance, Inc. (historically Nasdaq: WBA) and related securities, with AI-powered tools to help interpret the regulatory record. These documents trace the company’s transition from a publicly traded integrated healthcare, pharmacy and retail group to a privately held subsidiary of Blazing Star Parent, LLC, an affiliate of Sycamore Partners.
Among the most significant filings is the Form 8-K dated August 28, 2025, which reports the completion of the merger of Blazing Star Merger Sub, Inc. with and into Walgreens Boots Alliance, Inc. This filing explains that each share of company common stock was converted into the right to receive cash consideration and a divested asset proceed right, and that the company would become a wholly owned subsidiary of Blazing Star Parent, LLC. The same Form 8-K also describes the termination of certain credit facilities and the notice to The Nasdaq Stock Market LLC that WBA common stock and specified notes would be removed from listing.
A related Form 25, filed on August 28, 2025, documents the removal of Walgreens Boots Alliance, Inc. common stock and certain notes from listing and registration on Nasdaq. Subsequently, a Form 15 filed on September 8, 2025 certifies the termination of registration of the company’s common stock and various series of notes under Section 12(g) of the Securities Exchange Act of 1934 and the suspension of the duty to file reports under Sections 13 and 15(d). Together, these filings confirm WBA’s delisting and deregistration following the merger.
Earlier Form 8-K filings provide additional context on the transaction and corporate actions. These include disclosures about the Agreement and Plan of Merger with Blazing Star Parent, LLC and Blazing Star Merger Sub, Inc., the special meeting of stockholders held to vote on the merger agreement, the temporary suspension of trading under employee benefit plans in connection with the transaction, and supplemental proxy statement disclosures addressing shareholder litigation and demand letters related to the merger. Another Form 8-K furnishes a press release announcing financial results for the fiscal quarter ended May 31, 2025.
Debt-related filings and referenced documents, including press releases by Blazing Star Merger Sub, Inc., describe tender offers and consent solicitations for multiple series of Walgreens Boots Alliance, Inc. and Walgreen Co. notes, along with pricing terms, early tender results and extensions of expiration times. These materials are relevant for understanding how the company and its acquirer managed outstanding debt securities around the time of the merger.
On this SEC filings page, users can review these historical documents in one place. AI-powered summaries highlight key terms from complex forms such as Form 8-K, Form 25 and Form 15, explain the implications of delisting and deregistration, and clarify how equity and debt holders were affected by the merger. Real-time connections to the EDGAR system ensure that filings related to WBA’s historical record are captured, while AI tools help interpret legal and financial language so that readers can more easily understand corporate actions, capital structure changes and the company’s transition from public to private ownership.
Walgreens Boots Alliance (Nasdaq: WBA) filed its Q3 FY25 10-Q for the quarter ended May 31 2025. The filing confirms three operating segments—United States Retail Pharmacy, International and US Healthcare—and details the ongoing Footprint Optimization Program and Transformational Cost Management Program, which generated asset impairments, lease-related exit costs and severance charges across segments.
Liquidity updates include a new April 2025 Accounts Receivable Revolving Facility and disclosure of $3.6 bn notes due 2025 and $2.125 bn notes due 2026. The company also consolidates a variable-interest entity and notes subsequent-event activity related to its Cencora equity investment.
Management signals continued store rationalization and cost reduction to support US Healthcare growth while addressing near-term refinancing needs.
Walgreens Boots Alliance (Nasdaq: WBA) filed a Form 8-K under Item 2.02 to furnish its fiscal third-quarter 2025 results (quarter ended May 31 2025). A detailed press release is attached as Exhibit 99.1 and incorporated by reference; the body of the 8-K contains no financial tables. The information is "furnished," not "filed," avoiding Section 18 liability. No guidance revisions, strategic transactions or other material events were disclosed. The sole purpose is compliance with Regulation FD—making the earnings release simultaneously available to all investors. The report was signed by CFO Manmohan Mahajan on June 26 2025.